有危险 发表于 2025-3-25 06:02:09

http://reply.papertrans.cn/1/56/5572/5572-21.png

或者发神韵 发表于 2025-3-25 11:03:31

Submitted on: 29 August 2022.
Revised on: 07 December 2022.
Accepted on: 17 December 2022.

___________________CLINICAL AND EXPERIMENTAL RHEUMATOLOGY

省略 发表于 2025-3-25 12:13:23

Submitted on: 25 March 2012.
Revised on: 21 June 2012.
Accepted on: 11 July 2012.

___________________CLINICAL AND EXPERIMENTAL RHEUMATOLOGY

FILTH 发表于 2025-3-25 17:24:24

http://reply.papertrans.cn/1/56/5572/5572-24.png

微尘 发表于 2025-3-25 20:37:10

Submitted on: 03 February 2005.
Revised on: 29 March 2005.
Accepted on: 10 April 2005.

___________________CLINICAL AND EXPERIMENTAL RHEUMATOLOGY

overweight 发表于 2025-3-26 03:40:35

Submitted on: 19 July 2021.
Revised on: 30 September 2021.
Accepted on: 19 November 2021.

___________________CLINICAL AND EXPERIMENTAL RHEUMATOLOGY

MOAT 发表于 2025-3-26 04:52:35

http://reply.papertrans.cn/1/56/5572/5572-27.png

majestic 发表于 2025-3-26 09:49:57

http://reply.papertrans.cn/1/56/5572/5572-28.png

Glycogen 发表于 2025-3-26 12:44:43

Submitted on: 10 September 2016.
Revised on: 04 December 2016.
Accepted on: 09 January 2017.

___________________CLINICAL AND EXPERIMENTAL RHEUMATOLOGY

enchant 发表于 2025-3-26 17:38:07

http://reply.papertrans.cn/1/56/5572/5572-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2024/2025影响因子:3.481 (CLIN EXP RHEUMATOL) (0392-856X). (RHEUMATOLOGY)(风湿病学)